Printable PDF - Tessenderlo Group

As far as glycine is concerned, Tessenderlo Group continued to face extremely low prices from Chinese producers.
This had an impact on profitability. Cost reduction measures have been implemented.
Tessenderlo Group acquired the remaining shares in its Chinese manufacturing unit in Taile to become its sole
shareholder.
Investments were made in the various sites to increase the flexibility of some production units and to enable
the manufacture of new derivatives.
At Tessenderlo UK restructuring continued in order to optimise the production of chlorotoluenes within the
group. In the Widnes facility the company commissioned up a new production unit for the manufacture of
benzyl alcohol, a non toxic additive used in paints and fragrances and consumed in many other industrial
processes. The new unit, which boasts state of the art manufacturing technology, is the first major investment
by Tessenderlo Group in the Widnes facility since its acquisition in 2001.
Strategy and prospects
Tessenderlo Group will continue to expand production at the existing sites, where it has facilities for the treatment
of residual substances, and to expand its activities in derivatives of its key raw materials.
As in the past, it will examine opportunities to provide outsourcing facilities to both the pharmaceutical and
the aroma chemical industries. The business units will be supported by the central research laboratories and
the on-site technical teams, in both new product introductions and improvements and extensions of our
existing techniques and processes.
Tessenderlo Group continues to seek acquisitions that will create substantial synergies with the current production
units.
33